CVE-2026-67558: Mira Hormone Monitor, Mira Android App Authentication bypass by spoofing

Severity: high (CVSS 7.4 v3.1)
Exploited in the wild: not listed in CISA KEV
EPSS: 0.3% probability of exploitation in the next 30 days
Public exploit or detection template: none known
Published: 2026-08-11 · updated 2026-09-01
Weakness: CWE-290

Description

The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.

Affected products

Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Android App: 4.5.15.4
Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Firmware: 1.7.1.47

References

https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-223-01.json
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-223-01

Get alerted when CVE-2026-67558 or the next vulnerability affects your stack